Last reviewed · How we verify
CT-044 HCl
At a glance
| Generic name | CT-044 HCl |
|---|---|
| Sponsor | Lotus Clinical Research, LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CT-044 HCl CI brief — competitive landscape report
- CT-044 HCl updates RSS · CI watch RSS
- Lotus Clinical Research, LLC portfolio CI